U. K. Scientists Fear Government Will Muzzle Research Reports

New Rules Seen As Serious Threats To Academic Freedom LONDON--Gerald Draper is a worried man. Head of the Childhood Cancer Research Group at Oxford University, he often speaks at meetings of parents who live near nuclear installations, helping them understand why the risk of radiation-induced leukemia in their children is small. It is a daunting task, because the question of whether leukemia rates rise around nuclear power plants is one of the most contentious scientific issues in Britain.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

LONDON--Gerald Draper is a worried man. Head of the Childhood Cancer Research Group at Oxford University, he often speaks at meetings of parents who live near nuclear installations, helping them understand why the risk of radiation-induced leukemia in their children is small.

It is a daunting task, because the question of whether leukemia rates rise around nuclear power plants is one of the most contentious scientific issues in Britain. But now, the British government has made Draper’s job even more difficult. It is trying to make him sign a contract that could prevent him from publishing his work. If his research showed even small clusters of leukemia, would the government muzzle him, Draper wonders? And if so, what parent would ever believe that he is telling the truth about nuclear power? The new research contracts, say Draper and scores of other scientists across Britain, represent an ominous and serious threat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Smith

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio